Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Pulmonary Hypertension

  Free Subscription


05.10.2026

1 AIDS
1 Am Heart J Plus
1 Am J Med
1 Am J Med Sci
1 Am J Respir Cell Mol Biol
1 Ann Afr Med
1 Ann Pediatr Cardiol
1 Antioxidants (Basel)
1 Arterioscler Thromb Vasc Biol
1 bioRxiv
1 BMJ Open Respir Res
1 Br J Clin Pharmacol
1 Br J Pharmacol
1 Can Respir J
1 CHEST Pulm
1 Circ J
1 Clin Exp Hypertens
1 Diagnostics (Basel)
1 Echo Res Pract
1 Echocardiography
2 ERJ Open Res
1 Eur J Radiol
1 Front Pediatr
1 Genes (Basel)
3 Int J Mol Sci
1 Int J Obstet Anesth
1 J Am Heart Assoc
1 J Clin Med
1 J Diabetes Metab Disord
1 J Heart Lung Transplant
1 J Paediatr Child Health
1 J Physiol
1 J Thromb Haemost
1 JACC Case Rep
1 Magn Reson Med
1 Med Care
2 Medicine (Baltimore)
1 Microorganisms
1 Mymensingh Med J
1 Pediatr Res
1 Res Heart Yield Transl Med
1 Rheumatology (Oxford)
1 Sisli Etfal Hastan Tip Bul
2 Ther Adv Respir Dis
1 World J Pediatr Congenit Heart Surg


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. FERNANDES GARCIA MV, Lahm T
    HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.
    AIDS. 2026;40:1773-1776.
    PubMed         Abstract available


    Am Heart J Plus

  2. PRINCIBA DB, Kulkarni RR
    Comment on "Artificial intelligence enhanced contemporary pulmonary hypertension care".
    Am Heart J Plus. 2026;70:100893.
    PubMed        


    Am J Med

  3. GOLDHABER SZ, Rashedi S, Pfeferman M, Amalan C, et al
    Alert-Based Computerized Decision Support to Increase Screening for Pulmonary Hypertension after Pulmonary Embolism: The CTEPH-DETECT Trial.
    Am J Med. 2026 Sep 30:S0002-9343(26)00700-X. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Am J Med Sci

  4. KABALAK PA, Soyler Y, Cengiz TI, Celik M, et al
    Management of Pulmonary Hypertension in Interstitial Lung Disease Without Access to Inhaled Treprostinil: A Case Series from a Resource-Limited Setting.
    Am J Med Sci. 2026 Oct 2:S0002-9629(26)00366-6. doi: 10.1016/j.amjms.2026.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  5. PETROVIC A, Pak O, Schneider JN, Ewert J, et al
    Role of carbonic anhydrases 9 and 12 in hypoxia and non-hypoxia associated pulmonary hypertension.
    Am J Respir Cell Mol Biol. 2026 Sep 30:aanag182. doi: 10.1093.
    PubMed         Abstract available


    Ann Afr Med

  6. KANAKARAJU K, Paulose A, Ilangovan R, Rangabashyam SK, et al
    Late Presentation of Lutembacher Syndrome with Severe Pulmonary Hypertension and Tricuspid Regurgitation Complicated by Lower Respiratory Tract Infection in an Elderly Female: A Fatal Case Report.
    Ann Afr Med. 2026 Sep 25. doi: 10.4103.
    PubMed         Abstract available


    Ann Pediatr Cardiol

  7. ARUN BABU T, Sharmila V
    Sildenafil and fetomaternal outcomes in pregnancy-associated pulmonary hypertension.
    Ann Pediatr Cardiol. 2026;19:623-624.
    PubMed        


    Antioxidants (Basel)

  8. YANG S, Li L, Zhang J, Qiao X, et al
    Glutathione Redox Changes in Pulmonary Arterial Blood After Remote Ischemic Conditioning in Pulmonary Hypertension: A Single-Arm Pilot Study.
    Antioxidants (Basel). 2026;15:1203.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  9. VAN LEENT MMT, St Hillaire T, Sivalokanathan S, Morita H, et al
    PET Imaging in Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2026 Oct 1. doi: 10.1161/ATVBAHA.126.324761.
    PubMed         Abstract available


    bioRxiv

  10. OLIVEIRA AC, da Silva F, Zhang Y, Alves MD, et al
    TREM2 Orchestrates Myeloid Cell Programming and Immune Dysregulation in Pulmonary Hypertension.
    bioRxiv [Preprint]. 2026 Sep 24:2026.09.18.752808.
    PubMed         Abstract available


    BMJ Open Respir Res

  11. VELLA A, Muller J, Omuralieva A, Titz A, et al
    Effects of high-dose supplemental oxygen therapy on pulmonary haemodynamics at 3250 m in high-altitude residents at risk for pulmonary hypertension.
    BMJ Open Respir Res. 2026;13:e004376.
    PubMed         Abstract available


    Br J Clin Pharmacol

  12. MIURA M, Tanaka S, Aihara R, Yamamoto S, et al
    Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.
    Br J Clin Pharmacol. 2026;92:3611-3621.
    PubMed         Abstract available


    Br J Pharmacol

  13. GONG X, Wang Y, Kang S, Zhang Z, et al
    Sinapine thiocyanate (ST) ameliorates endothelial cell dysfunction by targeting chloride intracellular channel 4 (CLIC4) to treat hypoxia-induced pulmonary hypertension.
    Br J Pharmacol. 2026 Sep 30. doi: 10.1111/bph.70676.
    PubMed         Abstract available


    Can Respir J

  14. WANG Y, Wu Q, Zhang X, Sun Z, et al
    High-Frequency Oscillatory Ventilation Combined With Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Single-Center Randomized Clinical Trial.
    Can Respir J. 2026;2026:e8717590.
    PubMed         Abstract available


    CHEST Pulm

  15. RAZA A, Rali P, Naranjo MT, Gayen S, et al
    Can Quantitative CT Scan Analysis of Pulmonary Parenchymal and Vascular Characteristics Help to Differentiate Among Various Phenotypes of COPD Associated With Pulmonary Hypertension?
    CHEST Pulm. 2026;4:100244.
    PubMed         Abstract available


    Circ J

  16. GELEN MA, Yildiz G, Bolayir HA, Karasu M, et al
    Platelet-Albumin-Bilirubin Index for Predicting Hospitalization and Mortality in Pulmonary Hypertension.
    Circ J. 2026 Sep 30. doi: 10.1253/circj.CJ-26-0436.
    PubMed         Abstract available


    Clin Exp Hypertens

  17. TANG W, Cai J, Zhang S, Li Y, et al
    Preliminary study of individualized therapy for ventricular septal defect with severe pulmonary arterial hypertension.
    Clin Exp Hypertens. 2026;48:2734004.
    PubMed         Abstract available


    Diagnostics (Basel)

  18. AHMED F, Zulfiqar A, Ali R, Shah SS, et al
    Correlation of Echocardiographic Right Ventricular Functional Parameters with CMR-Derived Right Ventricular Ejection Fraction in Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Diagnostics (Basel). 2026;16:2899.
    PubMed         Abstract available


    Echo Res Pract

  19. SHRIVASTAV A, Tivaskar S, Luharia A, Gomase S, et al
    Echocardiographic assessment of pulmonary hypertension: a hierarchical interpretive framework for clinical decision-making and echo laboratory practice.
    Echo Res Pract. 2026;13:35.
    PubMed         Abstract available


    Echocardiography

  20. LIU J, Wang Y
    Clinical Value of Real-Time Three-Dimensional Echocardiography for Evaluating Right Ventricular Structure and Function in Patients With Pulmonary Hypertension Across Different Echocardiographic Pulmonary Artery Systolic Pressure Strata.
    Echocardiography. 2026;43:e70621.
    PubMed         Abstract available


    ERJ Open Res

  21. JUTANT EM, Delarche B, Croquette M, Beurnier A, et al
    Pulmonary vascular reactivity in severe pulmonary hypertension associated with COPD.
    ERJ Open Res. 2026;12:01606-2025.
    PubMed         Abstract available

  22. HAAS SO, Benjamin N, Shaukat M, Schneider MA, et al
    Impaired BMPR2 signalling across pulmonary hypertension subgroups: a multicentre study.
    ERJ Open Res. 2026;12:01644-2025.
    PubMed         Abstract available


    Eur J Radiol

  23. LIU A, He P, Du J, Ma R, et al
    Quantitative lung perfusion in pulmonary vascular diseases: a comparative study of phase-resolved functional lung MRI and ventilation/perfusion SPECT.
    Eur J Radiol. 2026;204:113095.
    PubMed         Abstract available


    Front Pediatr

  24. GONZALEZ T, Simpkin CT, Dias Maia P, Archambault JL, et al
    Flow versus resistance: hemodynamic phenotyping of pulmonary hypertension in infants with shunts and concurrent lung disease.
    Front Pediatr. 2026;14:1880632.
    PubMed         Abstract available


    Genes (Basel)

  25. STOICA CI, Araniciu C, Ionut IA, Stana A, et al
    Type I Interferon Emerges as the Reproducible Core of a Shared Mitochondrial-Immune Transcriptomic Signature in Pulmonary Arterial Hypertension and Bipolar Disorder.
    Genes (Basel). 2026;17:1147.
    PubMed         Abstract available


    Int J Mol Sci

  26. LUCERO MJ, Nozik E, Hassell K, Irwin DC, et al
    Extracellular Hemoglobin, Hypoxia, and Macrophage-Mediated Pulmonary Vascular Remodeling in Hemolytic Disease.
    Int J Mol Sci. 2026;27:8170.
    PubMed         Abstract available

  27. WANG X, Jiang X, Li Z, Wang Y, et al
    Exploring the Toxicological Impacts of DOTP Exposure on Pulmonary Arterial Hypertension via Network Toxicology, Virtual Knockout, Molecular Docking and Experimental Validation.
    Int J Mol Sci. 2026;27:8064.
    PubMed         Abstract available

  28. ATCHISON B, Byars S, Prestes PR, Myers M, et al
    Integrated Analysis of Rat Pulmonary Hypertension Datasets Identifies Candidate circRNA Networks in Hypoxia-Exposed Pulmonary Artery Tissue.
    Int J Mol Sci. 2026;27:8195.
    PubMed         Abstract available


    Int J Obstet Anesth

  29. LADIB A, Ladib J, Bouzuita B, Chamtouri I, et al
    Maternal and neonatal outcomes in pregnant women with pulmonary hypertension: A retrospective study from a Tunisian tertiary center (2013-2023).
    Int J Obstet Anesth. 2026;68:105223.
    PubMed         Abstract available


    J Am Heart Assoc

  30. CHEN Z, He Z, Liu X, Chen Y, et al
    S100A9 Inhibition Mediates Aerobic Exercise Benefits in Pulmonary Hypertension.
    J Am Heart Assoc. 2026 Sep 29:e049578. doi: 10.1161/JAHA.125.049578.
    PubMed         Abstract available


    J Clin Med

  31. SKOCZYLAS I, Piegza J, Waligora M, Skoczylas M, et al
    The Impact of Balloon Pulmonary Angioplasty (BPA) on Changes in the Liver Fibrosis Index (FIB-4 Index) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    J Clin Med. 2026;15:7251.
    PubMed         Abstract available


    J Diabetes Metab Disord

  32. ZAHRA A, Shabahat H, Rizvi SVZ, Khan WI, et al
    Trends in mortality with pulmonary hypertension and diabetes mellitus as contributing causes of death among U.S. Adults, 1999-2024.
    J Diabetes Metab Disord. 2026;25:271.
    PubMed         Abstract available


    J Heart Lung Transplant

  33. WANG Q, Liang F, Du S, Li Q, et al
    Long-term Exposure to PM(2.5) and Risk of Adverse Pregnancy Events in Women with Pulmonary Hypertension: A Nationwide Multicenter Study.
    J Heart Lung Transplant. 2026 Sep 29:S1053-2498(26)02108.
    PubMed         Abstract available


    J Paediatr Child Health

  34. WUYTS EWV, Van Horebeek I, Devlieger R
    Prenatal Presentation of Congenital Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins: A Case Initially Suspected as Posterior Urethral Valves.
    J Paediatr Child Health. 2026 Jul 11. doi: 10.1111/jpc.70502.
    PubMed         Abstract available


    J Physiol

  35. HAGHEBAERT M, Varsos P, Meiburg R, Vignon-Clementel I, et al
    A comparative study of lumped heart models for personalized medicine through sensitivity and identifiability analysis.
    J Physiol. 2026;604:8167-8200.
    PubMed         Abstract available


    J Thromb Haemost

  36. BERTOLETTI L, Chapelle C
    Extended anticoagulation with edoxaban in chronic thromboembolic pulmonary hypertension: reassuring real-world data, but can direct oral anticoagulants systematically replace vitamin K antagonists?
    J Thromb Haemost. 2026;24:3450-3452.
    PubMed        


    JACC Case Rep

  37. SAEED M, Sabanci R, Ghumman GM, Tahir A, et al
    BATMAN-Assisted Valve-in-Valve TMVR With Planned Hemodynamic Support in Severe Pulmonary Hypertension.
    JACC Case Rep. 2026;31:110039.
    PubMed         Abstract available


    Magn Reson Med

  38. ANDERSEN MP, Kristensen MH, Hansen ESS, Schulte RF, et al
    Correlating Pulmonary Hemodynamics With HP (129)Xe Dissolved-Phase MRSI in a Controlled Porcine Intervention Study.
    Magn Reson Med. 2026;96:2588-2600.
    PubMed         Abstract available


    Med Care

  39. GILLMEYER KR, Vimalananda VG, Sun L, Rinne ST, et al
    Resources Available for Pulmonary Hypertension Care Across Veterans Health Administration Medical Centers: Results From a Multicenter Survey.
    Med Care. 2026 Oct 1. doi: 10.1097/MLR.0000000000002386.
    PubMed         Abstract available


    Medicine (Baltimore)

  40. DAN Y, Xu G, Chen H, Li H, et al
    Safety assessment of ambrisentan based on the FDA Adverse Event Reporting System.
    Medicine (Baltimore). 2026;105:e50893.
    PubMed         Abstract available

  41. KANG MK, Kim KI, Ryu J, Shin DG, et al
    Echocardiographic factors suggestive of pulmonary hypertension in patients with mediastinal tumors: A single-center observational study.
    Medicine (Baltimore). 2026;105:e50924.
    PubMed         Abstract available


    Microorganisms

  42. AKHMEDOVA N, Kholov G, Ochilov U, Shonazarova N, et al
    Airway and Gut Dysbiosis, Infectious Exacerbations and Pulmonary Vascular Remodelling in COPD-Associated Pulmonary Hypertension: Microbial Mechanisms, Causal Uncertainty and Therapeutic Implications.
    Microorganisms. 2026;14:1954.
    PubMed         Abstract available


    Mymensingh Med J

  43. SHEIKH N, Ahmed CM, Arzu J, Jamali Z, et al
    Outcome of 30 Pregnant Women with Pulmonary Hypertension at Bangladesh Medical University, Dhaka, Bangladesh.
    Mymensingh Med J. 2026;35:1172-1179.
    PubMed         Abstract available


    Pediatr Res

  44. FUENTES-MENDOZA J, Sernaque-Paz M, Cruz-Riquelme D, Zavaleta-Corvera C, et al
    Sildenafil in bronchopulmonary dysplasia-associated pulmonary hypertension: developmental and translational insights.
    Pediatr Res. 2026 Sep 29. doi: 10.1038/s41390-026-05480.
    PubMed         Abstract available


    Res Heart Yield Transl Med

  45. AHMADI F, Parnia R, Astani B, Keshmiri MS, et al
    Successful Pregnancy in Chronic Obstructive Pulmonary Hypertension Secondary to Pulmonary and Cardiac Hydatid Cysts: A Case Report.
    Res Heart Yield Transl Med. 2026;21:111-115.
    PubMed         Abstract available


    Rheumatology (Oxford)

  46. BAE SS, Rivero Gallegos D, Bozan F, Sambataro G, et al
    Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases, and impact on survival.
    Rheumatology (Oxford). 2026 Sep 29:keag543. doi: 10.1093.
    PubMed         Abstract available


    Sisli Etfal Hastan Tip Bul

  47. BILEN MM, Mese T, Yilmazer MM, Vuran G, et al
    Investigation of the Effects of Switching from Bosentan to Macitentan in Pediatric Pulmonary Hypertension Patients.
    Sisli Etfal Hastan Tip Bul. 2026;60:405-411.
    PubMed         Abstract available


    Ther Adv Respir Dis

  48. ASANO R, Kiko T, Kawabata T, Sano Y, et al
    Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2026;20:17534666261484754.
    PubMed         Abstract available

  49. LIU B, Yan W, Zhang H, Luo Q, et al
    Novel hepatic function-based prognostic prediction model for pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2026;20:17534666261493712.
    PubMed         Abstract available


    World J Pediatr Congenit Heart Surg

  50. ZHANG Y, Li Y, Mao Y, Hu X, et al
    Supracardiac Total Anomalous Pulmonary Venous Connection with Left Main Bronchial Compression in an Infant.
    World J Pediatr Congenit Heart Surg. 2026;17:863-866.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum